Predatory Bacteria in the Treatment of Infectious Diseases and Beyond

Area of Science:

• Microbiology
• Infectious Diseases
• Bacteriology

Background:

• Antimicrobial resistance (AMR) poses a significant global health threat, necessitating novel therapeutic strategies.
• The development of new antibiotics is slow, creating an urgent need for alternative treatments.
• Predatory bacteria, naturally occurring microorganisms, are being explored for their potential in combating resistant infections.

Purpose of the Study:

• To review the current evidence on the use of predatory bacteria as a therapeutic approach against infectious diseases.
• To evaluate the efficacy and safety of predatory bacteria in preclinical models of antimicrobial resistance.
• To identify the challenges and future directions for the clinical application of predatory bacteria.

Main Methods:

• Literature review of in vitro and in vivo studies investigating predatory bacteria against various pathogens.
• Analysis of data on pathogen elimination, immune stimulation, cytotoxicity, and safety in animal models.
• Assessment of existing applications of predatory bacteria in non-medical fields.

Main Results:

• In vitro studies indicate predatory bacteria can eliminate multidrug-resistant pathogens with minimal cytotoxicity and immune stimulation.
• In vivo animal studies demonstrate safety and efficacy in reducing bacterial load in infection models.
• Results show variability, suggesting dependence on specific animal models and bacterial strains.

Conclusions:

• Predatory bacteria represent a promising non-antimicrobial strategy for treating infections, especially those with AMR.
• Further research, including human clinical trials, is essential to establish their safety and efficacy in clinical settings.
• Successful development could lead to a novel class of treatments for bacterial infections.